Tag: Oxford Biomedica
-
Oxford Biomedica reports 36% decline in revenues for 2023
•
LONDON: Oxford Biomedica plc, a leading cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has released…
-
Oxford Biomedica transforms into a pure-play CDMO in cell and gene therapy
•
LONDON, UK: Oxford Biomedica, a leading cell and gene therapy CDMO, has announced a business update for the…
-
Oxford Biomedica to acquire 80% stake in AAV Manufacturing and Innovation Business
•
LONDON, UK: Oxford Biomedica has entered into an agreement with Homology Medicines Inc. to acquire an 80 per…
-
Oxford Biomedica signs development & supply agreement with Boehringer Ingelheim
•
OXFORD: Oxford Biomedica has signed a new three year Development & Supply Agreement (DSA) with Boehringer Ingelheim for…
-
Oxford Biomedica signs 5-year collaboration agreement with the Vaccines Manufacturing and Innovation Centre
•
OXFORD: Oxford Biomedica has signed a Collaboration Agreement with the Vaccines Manufacturing and Innovation Centre (VMIC), a not-for-profit…
-
Oxford Biomedica receives MHRA approval for the first two manufacturing suites in Oxbox
•
OXFORD: Oxford Biomedica plc has announced the successful outcome of their recent UK Medicines & Healthcare products Regulatory…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.